BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 8, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 2, 2008
View Archived Issues
BrainStorm reports results from rat study of NTF cells in Parkinson's disease
Read More
Novartis pays USD 25 million milestone payment to Antisoma in relation to ASA-404
Read More
4SC acquires stake in Nexigen and enters licensing agreement with ViroLogik
Read More
InSite signs Chinese licensing agreement with Essex Biotechnology for AzaSite
Read More
Human Genome Sciences presents an update on clinical development portfolio
Read More
Gene therapy for retinal albinism presented at the ASGT meeting
Read More
Murine von Willebrand disease ameliorated by helper-dependent adenovirus gene transfer
Read More
Boehringer Ingelheim gets first approval within E.U. for Actilyse
Read More
Antiinflammatory compound ND-07 improves experimental acute pancreatitis
Read More
Bristol-Myers Squibb to acquire cancer therapeutics company, Kosan Biosciences
Read More
FDA grants fast track to Wyeth's 13-valent pneumococcal conjugate vaccine
Read More
IntelGenx presents positive results from pilot pharmacokinetic study on CPI-300
Read More
Lipoxen reports phase I data for long-acting insulin candidate, SuliXen
Read More
SymBio completes enrollment in phase II study in indolent non-Hodgkin's lymphoma
Read More
Triphendiol safe in phase Ia pharmacokinetic study
Read More
Wyeth receives FDA approvable letter for Tygacil in community-acquired pneumonia
Read More
Phase I data show activity of NKTR-102 in solid tumor patients
Read More
Camurus reports positive phase II results for CAM-2028 in oral mucositis pain
Read More
Human Genome Sciences has initiated dosing in phase I HGS-1029
Read More
Novel antiinfective agents disclosed in recent GSK patents
Read More
Novel anti-HIV agents reported in recent patents
Read More
Nisshin Kyorin patent describes new therapeutic options for IBD
Read More
Genmab announces completion of pivotal phase III trial of ofatumumab in CLL
Read More